chartexchange

Attovia Therapeutics, Inc. (ATTO) Discusses ATTO-1310 Phase Ib Results in Chronic Pruritus and Atopic Dermatitis Transcript

Seeking Alpha | Nov 9, 2026 5:20 PM EST

Read original article